Shopping Cart
- Remove All
Your shopping cart is currently empty
ADH-6, a tripyridylamide compound, impedes the self-assembly of the aggregation-nucleating subdomain of mutant p53 DNA-binding domain (DBD). By targeting and dissociating mutant p53 aggregates in human cancer cells, ADH-6 reinstates p53's transcriptional activity, culminating in cell cycle arrest and apoptosis, thereby holding potential for cancer research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $2,570 | 10-14 weeks | |
| 50 mg | $3,380 | 10-14 weeks | |
| 100 mg | $4,600 | 10-14 weeks |
| Description | ADH-6, a tripyridylamide compound, impedes the self-assembly of the aggregation-nucleating subdomain of mutant p53 DNA-binding domain (DBD). By targeting and dissociating mutant p53 aggregates in human cancer cells, ADH-6 reinstates p53's transcriptional activity, culminating in cell cycle arrest and apoptosis, thereby holding potential for cancer research. |
| Molecular Weight | 640.64 |
| Formula | C29H36N8O9 |
| Cas No. | 2227429-65-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.